Biotechnology and medtech startups face a critical funding gap during the commercial validation phase, often struggling to secure capital for pilot scale-up, regulatory trials, and international patent filings. The BIRAC SEED Fund addresses this challenge by offering up to ₹1 Crore in seed capital, structured as equity, convertible debentures, or soft loans, to eligible startups through accredited bio-incubators.
Scheme Overview & Objective
The BIRAC SEED (Sustainable Entrepreneurship and Enterprise Development) Fund is an institutional investment initiative managed by the Biotechnology Industry Research Assistance Council (BIRAC), under the Department of Biotechnology (DBT), Government of India. Designed to bridge the financial gap for early-stage biotech and healthcare startups, the scheme provides patient, founder-friendly capital to support commercial validation, regulatory approvals, and market entry.
Startups can access up to ₹1 Crore in funding, delivered through premier bio-incubators like C-CAMP Bengaluru, Venture Center Pune, and IKP Knowledge Park Hyderabad. The capital is structured flexibly to meet the unique needs of life science ventures, with longer gestation periods and founder-aligned valuation terms.
Eligibility Criteria & Scope
To qualify for the BIRAC SEED Fund, startups must meet the following eligibility criteria:
- DPIIT-recognized Startups incorporated as a Private Limited Company in India, with less than 5 years of existence.
- Physically or virtually incubated at an officially approved BIRAC Bio-Incubator.
- At least 51% of equity shareholding owned by Indian resident citizens.
- Validated laboratory proof-of-concept or prototype in biotechnology, medtech, or healthcare.
- Clear roadmap for regulatory pathway, preclinical validation, and commercial launch.
- Founders with technical domain competence in life sciences, bioengineering, or clinical medicine.
The scheme covers sectors including diagnostics, biopharma, and agribio, providing a comprehensive support ecosystem for innovative life science ventures.
Key Financial & Growth Benefits
The BIRAC SEED Fund offers a range of financial and strategic benefits to accelerate startup growth:
- Substantial Seed Capital: Up to ₹1 Crore in funding, structured as equity, soft loan, or convertible debt.
- Premier Bio-Incubator Access: World-class research facilities, including BSL-2/3 labs, flow cytometry, and bioprocess cleanrooms.
- Regulatory & Clinical Guidance: Expert mentorship on CDSCO approvals, ethics committee filings, and international certifications.
- Patient Capital Terms: Founder-friendly valuation structures and longer gestation horizons tailored for life science cycles.
- Co-Investment Opportunities: Catalytic capital to unlock follow-on Series A rounds from healthcare VC funds.
- Global Bio-Partnering: Sponsored participation in major global bio-conventions like BIO USA and MedTech Innovator.
Application Procedure & Documents
The application process for the BIRAC SEED Fund involves the following steps:
- Identify and partner with an approved BIRAC Bio-Incubator.
- Prepare a detailed business plan, including clinical/regulatory roadmap and financial projections.
- Submit the application through the bio-incubator, along with the required documents.
- Undergo evaluation by BIRAC’s technical and financial experts.
- Receive funding upon approval, with capital disbursed in tranches based on milestones.
The required document checklist includes:
- Certificate of Incorporation, MoA / AoA, and Company PAN Card.
- DPIIT Startup Recognition Certificate & Bio-Incubator Incubation Agreement.
- Detailed Business Plan with Clinical / Regulatory Roadmap and Financial Projections.
- Itemized Budget Breakdown for the ₹1 Crore seed support.
- Audited Balance Sheets / CA Net Worth Certificate.
- Founders' KYC Documents (Aadhaar & PAN Cards).
- Company Bank Account Details & Cancelled Cheque.
Official FAQs
Q1: What is the maximum funding amount under the BIRAC SEED Fund?
A1: Startups can secure up to ₹1 Crore in seed capital, structured as equity, convertible debentures, or soft loans.
Q2: Who is eligible to apply for the BIRAC SEED Fund?
A2: DPIIT-recognized Startups incorporated as Private Limited Companies in India, with less than 5 years of existence, and incubated at an approved BIRAC Bio-Incubator.
Q3: What sectors are covered under the scheme?
A3: The scheme covers biotechnology, medtech, diagnostics, biopharma, and agribio sectors.
Q4: How is the funding structured?
A4: Funding is provided as equity, optionally convertible preference shares (OCPS), or low-interest soft loans, with patient capital terms tailored for life science ventures.
Q5: What are the key benefits of the BIRAC SEED Fund?
A5: Benefits include substantial seed capital, access to premier bio-incubators, regulatory and clinical guidance, patient capital terms, co-investment opportunities, and global bio-partnering access.
